P2.12. Beware: Tyrosine Kinase Inhibitors for Lung Cancers that Inhibit MATE-1 can Lead to "False” Decreases in Renal Function - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Monica Chen
Meta Tag
Speaker Monica Chen
Topic Metastatic NSCLC: Targeted Therapy - Other
tyrosine kinase inhibitors
kidney function
lung cancer patients
MATE-1 inhibition
serum creatinine levels
acute kidney injury
glomerular filtration rate
cystatin C
alternative causes
TKI treatment
Powered By